Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
Tran, Bao-Tram Thi, Gelin, Aurore, Durand, Sylvère, Texier, Matthieu, Daste, Amaury, Toullec, Clémence, Benihoud, Karim, Breuskin, Ingrid, Gorphe, Philippe, Garic, Florence, Brenner, Catherine, Le Tourneau, Christophe, Fayette, Jérôme, Niki, Toshiro, David, Muriel, Busson, Pierre, Even, Caroline
Published in Oncoimmunology (2023)
Published in Oncoimmunology (2023)
Get full text
Journal Article
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
Chevalier, Thomas, Daste, Amaury, Saada‐Bouzid, Esmaa, Loundou, Anderson, Peyraud, Florent, Lambert, Tiphaine, Le Tourneau, Christophe, Peyrade, Frédéric, Dupuis, Charlotte, Alfonsi, Marc, Fayette, Jérôme, Reure, Juliette, Huguet, Florence, Fakhry, Nicolas, Toullec, Clémence, Salas, Sébastien
Published in Cancer medicine (Malden, MA) (01.06.2021)
Published in Cancer medicine (Malden, MA) (01.06.2021)
Get full text
Journal Article
Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer
Mineur, Laurent, Vazquez, Léa, Belkacemi, Mohamed, Toullec, Clémence, Bentaleb, Newfel, Boustany, Rania, Plat, Frederi
Published in Current oncology (Toronto) (01.09.2023)
Published in Current oncology (Toronto) (01.09.2023)
Get full text
Journal Article
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial
Taïeb, Julien, André, Thierry, El Hajbi, Farid, Barbier, Emilie, Toullec, Clémence, Kim, Stefano, Bouche, Olivier, Di Fiore, Frederic, Chauvenet, Marion, Perrier, Hervé, Evesque, Ludovic, Laurent-Puig, Pierre, Emile, Jean-François, Bez, Jérémie, Lepage, Côme, Tougeron, David
Published in Digestive and liver disease (01.03.2021)
Published in Digestive and liver disease (01.03.2021)
Get full text
Journal Article
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study
Bergen, Elisabeth S., Pilla, Lorenzo, Auclin, Edouard, Ilhan-Mutlu, Aysegül, Prager, Gerald W., Pietrantonio, Filippo, Antista, Maria, Ghelardi, Filippo, Basile, Debora, Aprile, Giuseppe, Longarini, Raffaella, Hautefeuille, Vincent, Tougeron, David, Artru, Pascal, Mabro, May, Drouillard, Antoine, Roth, Gael, Ben Abdelghani, Meher, Clement, Inès, Toullec, Clemence, Mineur, Laurent, Guimbaud, Rosine, Taieb, Julien, Zaanan, Aziz
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2023)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.05.2023)
Get full text
Journal Article
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
Guigay, Joël, Fayette, Jérôme, Saada-Bouzid, Esma, Martin, Laurent, Capitain, Olivier, Castanie, Hélène, Vansteene, Damien, Schafhausen, Philippe, Johnson, Alison, Even, Caroline, Duplomb, Sophie, Evrard, Camille, Laguerre, Brigitte, Chevassus-Clément, Cécile, Sinigaglia, Laura, Keilholz, Ulrich, Bourhis, Jean, Mesia, Ricard, BABA-HAMED, Nabil, BABIN, Emmanuel, BERA, Guillaume, BETRIAN-LAGARDE, Sarah, BLOT, Emmanuel, BOREL, Christian, BRUYAS, Amandine, CALAIS, Gilles, CARPIUC, Ioana, CHAPET, Sophie, CHATELLIER, Thierry, CHELI, Sandrine, CLATOT, Florian, COJOCARASU, Oana, COUTTE, Alexandre, DALLOZ, Pierre, DELHOMMEAU, Melissa, DE RAUCOURT, Dominique, DEBOURDEAU, Philippe, DUBOS-ARVIS, Catherine, DUCOULOMBIER, Agnès, EL KOURI, Claude, FALKOWSKI, Sabrina, FERRAND, François-Regis, GATINEAU, Michel, GERVAIS, Radj, GRAS, Louis, HASBINI, Ali, HENAULT, Stéphane, HERRERA GOMEZ, Ruth Gabriela, HUGUET, Florence, LAGRANGE, Aurélie, LE FOLL, Christine, LINOT, Benjamin, LOPEZ, Qian, MAYACHE-BADIS, Lamia, MINNE, Floriane, NEIDHARDT, Eve Marie, PAVILLET, Julien, PEYRADE, Frédéric, POINTREAU, Yohann, RAMEE, Jean-François, RAUCHE, Camille, RICHARD, Sandrine, RIZZO, Claudia, ROLLAND, Frédéric, STEFANI, Laetitia, THERY, Jean-Christophe, TOULLEC, Clémence, TOURANI, Jean-Marc, TOUSSAINT, Philippe, VAULEON, Elodie, VIRET, Frédéric, WALER, Sabine, ATZPODIEN, Jens, FIETKAU, Rainer, GRANIZKA, Thordis, GUNTINAS-LICHINUS, Orlando, HADLER-MIKESCH, Kristina, HAHN, Dennis, INHESTERN, Johanna, KELLNER, Karolin, KLINGHAMMER, Konrad, KRONENBERGER, Roland, LUEDTKE-HECKENKAMP, Kerstin, PIRLICH, Markus, ROTHMANN, Frank, TOMETTEN, Mareike, WOHLFARTH, Sabine, ZEBRALLA, Veit, ZIPFEL, Matthias, ADANSA KLEIN, Juan Carlos, ARRAZUBI, Virginia, CABALLERO DAROQUI, Javier, CASTELO, Beatriz, GALLEGO, Oscar, IGLESIAS DOCAMPO, Lara Carmen, MARTINEZ DEL PRADO, Maria, MARTINEZ-TRUFERO, Javier, PASTOR BORGONON, Miguel, PEREZ RUIZ, Elisabeth, RUBIO CASADEVALL, Jordi
Published in The lancet oncology (01.04.2021)
Published in The lancet oncology (01.04.2021)
Get full text
Journal Article
Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
Botsen, Damien, Chabaud, Sylvie, Perrier, Hervé, Ammarguellat, Hanifa, Jestin-Le-Tallec, Véronique, Olesinski, Jonathan, Toullec, Clémence, Aparicio, Thomas, Ben Abdelghani, Meher, Borg, Christophe, Bouche, Olivier, Coutzac, Clélia, Devaud, Hervé, Di Fiore, Frédéric, Dubreuil, Olivier, Evesque, Ludovic, Huguenin, Bruno, Muller, Marie, Poureau, Pierre-Guillaume, Oularue, Emilie, Tougeron, David, Zaanan, Aziz, Ammari, Samy, De Sousa Carvalho, Nicolas, Decazes, Pierre, De La Fouchardiere, Christelle
Published in Digestive and liver disease (01.08.2024)
Published in Digestive and liver disease (01.08.2024)
Get full text
Journal Article
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
Taïeb, Julien, Bouche, Olivier, André, Thierry, Le Malicot, Karine, Laurent-Puig, Pierre, Bez, Jérémie, Toullec, Clémence, Borg, Christophe, Randrian, Violaine, Evesque, Ludovic, Corbinais, Stéphane, Perrier, Hervé, Buecher, Bruno, Di Fiore, Frederic, Gallois, Claire, Emile, Jean Francois, Lepage, Côme, Elhajbi, Farid, Tougeron, David
Published in JAMA oncology (01.10.2023)
Published in JAMA oncology (01.10.2023)
Get more information
Journal Article
Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME
Chevalier, Thomas, Daste, Amaury, Saada-Bouzid, Esmaa, Loundou, Anderson, Peyraud, Florent, Lambert, Tiphaine, Le Tourneau, Christophe, Peyrade, Frédéric, Dupuis, Charlotte, Alfonsi, Marc, Fayette, Jérôme, Reure, Juliette, Huguet, Florence, Fakhry, Nicolas, Toullec, Clémence, Salas, Sébastien
Published in Cancer medicine (Malden, MA) (25.05.2021)
Published in Cancer medicine (Malden, MA) (25.05.2021)
Get full text
Journal Article
A PK/PD mathematical model to forecast severe toxicities in pancreatic cancer patients treated with FOLFIRINOX regimen
Deyme, Laure, Gilabert, Marine, Mineur, Laurent, Toullec, Clemence, Gasmi, Mohamed, Ciccolini, Joseph, Barbolosi, Dominique, Gattacceca, Florence
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Maintenance therapy with olaparib or selumetinib plus durvalumab (S+D) according to genetic profile of metastatic pancreatic adenocarcinoma (m-PDAC) controlled with modified FOLFIRINOX (mFFX): A phase II randomized MAZEPPA GERCOR D19-02 PRODIGE-72 study
Hammel, Pascal, Ben Abdelghani, Meher, Roth, Gael, Ulusakarya, Ayhan, Ghiringhelli, François, Toullec, Clemence, Borg, Christophe, Hentic Dhome, Olivia, Trouilloud, Isabelle, Dahan, Laetitia, Hiret, Sandrine, Bouche, Olivier, Rinaldi, Yves, Blanc, Jean-Frédéric, De La Fouchardiere, Christelle, Neuzillet, Cindy, Kamal, Maud, Falcoz, Antoine, Turpin, Anthony, Guimbaud, Rosine
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab combined with weekly paclitaxel carboplatin in first-line in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible for cisplatin-based therapies
Fayette, Jerome, Cropet, Claire, Gautier, Julien, Toullec, Clemence, Burgy, Mickael, Bruyas, Amandine, Sire, Christian, Lagrange, Aurelie, Clatot, Florian, Calderon, Benoit, Vinches, Marie, Iacob, Mariana, Martin, Laurent, Neidhardt Berard, Eve Marie, Kaminsky, Marie-Christine, Vansteene, Damien, Salas, Sébastien, Champagnac, Anne, Pérol, David, Bourhis, Jean
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Assessment of an emergency 14-day (d) integrative supportive care program (14-EISCP) followed by early chemotherapy (CTx) in symptomatic patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): A prospective ARCAD cohort study
Rousseau, Benoit, Falcoz, Antoine, Toullec, Clemence, Lecomte, Thierry, Lambert, Aurélien, Tournigand, Christophe, Guerin-Meyer, Veronique, Louvet, Christophe, Trouilloud, Isabelle, Rinaldi, Yves, Coriat, Romain, Dauba, Jerome, Neuzillet, Cindy, Andre, Thierry, Bachet, Jean-Baptiste, Cros, Jerome, De La Fouchardiere, Christelle, Garcia-Larnicol, Marie-Line, De Gramont, Aimery, Hammel, Pascal
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
Adhoute, Xavier, De Matharel, Marie, Mineur, Laurent, Pénaranda, Guillaume, Ouizeman, Dann, Toullec, Clemence, Tran, Albert, Castellani, Paul, Rollet, Armelle, Oules, Valérie, Perrier, Hervé, Si Ahmed, Si Nafa, Bourliere, Marc, Anty, Rodolphe
Published in World journal of gastrointestinal oncology (15.08.2022)
Published in World journal of gastrointestinal oncology (15.08.2022)
Get full text
Journal Article
Sarcomas of the digestive tract (excluding GISTs) (SDT): A study of 63 patients from the French Sarcoma Group (GSF) database
Toullec, Clemence, Coindre, Jean-Michel, Blay, Jean-Yves, Ranchere, Dominique, Meeus, Pierre, Stoeckle, Eberhard, Bui, Binh, Bonvalot, Sylvie, Le Cesne, Axel, Terrier, Philippe, Duffaud, Florence, Bertucci, Francois, Cupissol, Didier, Isambert, Nicolas, piperno Neumann, Sophie, Baumstarck, Karine, Salas, Sebastien
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors
Tran, Bao-Tram Thi, Gelin, Aurore, Durand, Sylvère, Texier, Matthieu, Daste, Amaury, Toullec, Clémence, Benihoud, Karim, Breuskin, Ingrid, Gorphe, Philippe, Garic, Florence, Brenner, Catherine, Le Tourneau, Christophe, Fayette, Jérôme, Niki, Toshiro, David, Muriel, Busson, Pierre, Even, Caroline
Published in OncoImmunology (31.12.2023)
Published in OncoImmunology (31.12.2023)
Get full text
Report